Corporate ActionJul 2, 2026, 05:07 PM
Sintx Technologies Resolves Abeyance Shares, Issues New Warrants
AI Summary
Sintx Technologies, Inc. entered into a Letter Agreement with MedTech Ceramics, LP to resolve 507,254 abeyance shares and restructure an existing warrant. The agreement involves issuing 255,267 common shares, exchanging 251,987 abeyance shares for a pre-funded warrant, and replacing an existing warrant for 760,881 shares with a new warrant to purchase 1,268,135 shares at $2.14 per share. This action aims to manage the company's capital structure and improve its stockholders' equity position.
Key Highlights
- Sintx Technologies issued 255,267 common shares from abeyance to MedTech Ceramics, LP.
- Remaining 251,987 abeyance shares were exchanged for a pre-funded common stock purchase warrant.
- An existing warrant for 760,881 shares was cancelled.
- A new common stock purchase warrant for 1,268,135 shares was issued at an exercise price of $2.14 per share.
- The new warrant has a five-year term and includes a full-ratchet downward adjustment clause for dilutive equity financing.
- Company agreed to file a resale registration statement for shares issuable under the new warrant within 45 days.
- All warrants and share issuances are subject to a 9.99% beneficial ownership limitation.
Price Impact
More from SINT